Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleanor M Perfetto

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Journal of Managed Care & Specialty Pharmacy|January 28, 2025
Emerging trends in patient experience data: Perspectives on the 2024 AMCP Foundation SurveyEleanor M Perfetto
Journal of Managed Care & Specialty Pharmacy|January 31, 2025
Emerging trends in patient experience data: Perspectives on the 2024 AMCP Foundation SurveyEleanor M Perfetto
The American Journal of Managed Care|November 1, 2017
Letter to the editorsEleanor M Perfetto
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2018
ISPOR's Initiative on US Value Assessment Frameworks: A Missed Opportunity for ISPOR and PatientsEleanor M Perfetto
Journal of Managed Care & Specialty Pharmacy|June 28, 2016
What Are the Incentives for Medicare Prescription Drug Plans to Consider Long-Term Outcomes and Cost?Anna Hung, Eleanor M Perfetto
Managed Care Interface|June 29, 2002
Escherichia coli resistance in uncomplicated urinary tract infection: a model for determining when to change first-line empirical antibiotic choiceEleanor M Perfetto, Kathleen Gondek
The American Journal of Managed Care|September 16, 2005
Treatment of overactive bladder: a model comparing extended-release formulations of tolterodine and oxybutyninEleanor M Perfetto, Prasun Subedi, Zhanna Jumadilova
Journal of Managed Care Pharmacy : JMCP|November 15, 2011
Something old, something new, something borrowed...comparative effectiveness research: a policy perspectivePrasun Subedi, Eleanor M Perfetto, Riaz Ali
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Economic burden of uncomplicated urinary tract infections: direct, indirect and intangible costsKaren N Keating, Eleanor M Perfetto, Prasun Subedi
Clinical Drug Investigation|May 30, 2007
Fluoroquinolone therapy for uncomplicated skin and skin structure infections : a retrospective database comparison of treatment duration, failures and chargesKaren N Keating, Howard Friedman, Eleanor M Perfetto
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Journal of Managed Care & Specialty Pharmacy|January 28, 2025
Emerging trends in patient experience data: Perspectives on the 2024 AMCP Foundation SurveyEleanor M Perfetto
Journal of Managed Care & Specialty Pharmacy|January 31, 2025
Emerging trends in patient experience data: Perspectives on the 2024 AMCP Foundation SurveyEleanor M Perfetto
The American Journal of Managed Care|November 1, 2017
Letter to the editorsEleanor M Perfetto
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2018
ISPOR's Initiative on US Value Assessment Frameworks: A Missed Opportunity for ISPOR and PatientsEleanor M Perfetto
Journal of Managed Care & Specialty Pharmacy|June 28, 2016
What Are the Incentives for Medicare Prescription Drug Plans to Consider Long-Term Outcomes and Cost?Anna Hung, Eleanor M Perfetto
Managed Care Interface|June 29, 2002
Escherichia coli resistance in uncomplicated urinary tract infection: a model for determining when to change first-line empirical antibiotic choiceEleanor M Perfetto, Kathleen Gondek
The American Journal of Managed Care|September 16, 2005
Treatment of overactive bladder: a model comparing extended-release formulations of tolterodine and oxybutyninEleanor M Perfetto, Prasun Subedi, Zhanna Jumadilova
Journal of Managed Care Pharmacy : JMCP|November 15, 2011
Something old, something new, something borrowed...comparative effectiveness research: a policy perspectivePrasun Subedi, Eleanor M Perfetto, Riaz Ali
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Economic burden of uncomplicated urinary tract infections: direct, indirect and intangible costsKaren N Keating, Eleanor M Perfetto, Prasun Subedi
Clinical Drug Investigation|May 30, 2007
Fluoroquinolone therapy for uncomplicated skin and skin structure infections : a retrospective database comparison of treatment duration, failures and chargesKaren N Keating, Howard Friedman, Eleanor M Perfetto
Pageof 7